These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18789152)

  • 1. Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145.
    Kucukzeybek Y; Gul MK; Cengiz E; Erten C; Karaca B; Gorumlu G; Atmaca H; Uzunoglu S; Karabulut B; Sanli UA; Uslu R
    J Exp Clin Cancer Res; 2008 Sep; 27(1):37. PubMed ID: 18789152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K-AKT pathway.
    Dirican A; Atmaca H; Bozkurt E; Erten C; Karaca B; Uslu R
    Clin Transl Oncol; 2015 Feb; 17(2):145-51. PubMed ID: 25060568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL.
    Hwang JJ; Kim YS; Kim T; Kim MJ; Jeong IG; Lee JH; Choi J; Jang S; Ro S; Kim CS
    Invest New Drugs; 2012 Aug; 30(4):1434-42. PubMed ID: 21773733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells.
    Karabulut B; Erten C; Gul MK; Cengiz E; Karaca B; Kucukzeybek Y; Gorumlu G; Atmaca H; Uzunoglu S; Sanli UA; Baran Y; Uslu R
    Cell Biol Int; 2009 Feb; 33(2):239-46. PubMed ID: 19103299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line.
    Fabbri F; Brigliadori G; Carloni S; Ulivi P; Vannini I; Tesei A; Silvestrini R; Amadori D; Zoli W
    J Transl Med; 2008 Aug; 6():43. PubMed ID: 18691406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin.
    Hu H; Li GX; Wang L; Watts J; Combs GF; Lü J
    Clin Cancer Res; 2008 Feb; 14(4):1150-8. PubMed ID: 18281549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: a paradigm of synergistic molecular targeting treatment for ovarian cancer.
    Karabulut B; Karaca B; Varol U; Muslu U; Cakar B; Atmaca H; Kisim A; Uzunoglu S; Uslu R
    J Exp Clin Cancer Res; 2010 Jul; 29(1):102. PubMed ID: 20673323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential combination of flavopiridol and docetaxel reduces the levels of X-linked inhibitor of apoptosis and AKT proteins and stimulates apoptosis in human LNCaP prostate cancer cells.
    Gomez LA; de Las Pozas A; Perez-Stable C
    Mol Cancer Ther; 2006 May; 5(5):1216-26. PubMed ID: 16731754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zoledronic acid increases cytotoxicity by inducing apoptosis in hormone and docetaxel-resistant prostate cancer cell lines.
    Varol U; Degirmenci M; Karaca B; Atmaca H; Kisim A; Uzunoglu S; Sezgin C; Sanli UA; Uslu R
    Tumour Biol; 2015 Feb; 36(2):779-86. PubMed ID: 25293519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation.
    Morikawa Y; Koike H; Sekine Y; Matsui H; Shibata Y; Ito K; Suzuki K
    Biochem Biophys Res Commun; 2012 Mar; 419(3):584-9. PubMed ID: 22387542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3,3'-Diindolylmethane enhances taxotere-induced apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
    Rahman KM; Banerjee S; Ali S; Ahmad A; Wang Z; Kong D; Sakr WA
    Cancer Res; 2009 May; 69(10):4468-75. PubMed ID: 19435906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of a novel docetaxel sensitizer, garlic-derived S-allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer.
    Howard EW; Lee DT; Chiu YT; Chua CW; Wang X; Wong YC
    Int J Cancer; 2008 May; 122(9):1941-8. PubMed ID: 18183597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of growth factors in hormone- and drug-resistant prostate cancer cells by synergistic combination of docetaxel and octreotide.
    Erten C; Karaca B; Kucukzeybek Y; Gorumlu G; Cengiz E; Gul MK; Atmaca H; Uzunoglu S; Karabulut B; Sanli UA; Uslu R
    BJU Int; 2009 Jul; 104(1):107-14. PubMed ID: 19191785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of apoptosis-related molecules by synergistic combination of all-trans retinoic acid and zoledronic acid in hormone-refractory prostate cancer cell lines.
    Karabulut B; Karaca B; Atmaca H; Kisim A; Uzunoglu S; Sezgin C; Uslu R
    Mol Biol Rep; 2011 Jan; 38(1):249-59. PubMed ID: 20349282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of methylselenocysteine and docetaxel synergistic activity in prostate cancer cells.
    Azrak RG; Frank CL; Ling X; Slocum HK; Li F; Foster BA; Rustum YM
    Mol Cancer Ther; 2006 Oct; 5(10):2540-8. PubMed ID: 17041098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of docetaxel-induced apoptosis and cell cycle arrest by all- trans retinoic acid in prostate cancer cells.
    Nehmé A; Varadarajan P; Sellakumar G; Gerhold M; Niedner H; Zhang Q; Lin X; Christen RD
    Br J Cancer; 2001 Jun; 84(11):1571-6. PubMed ID: 11384110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitor potentiates anticancer effect of docetaxel via modulation of Bcl-2 family proteins and tubulin in hormone refractory prostate cancer cells.
    Hwang JJ; Kim YS; Kim MJ; Kim DE; Jeong IG; Kim CS
    J Urol; 2010 Dec; 184(6):2557-64. PubMed ID: 21030039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta1 inhibits all-trans retinoic acid-induced apoptosis.
    Soucek K; Pacherník J; Kubala L; Vondrácek J; Hofmanová J; Kozubík A
    Leuk Res; 2006 May; 30(5):607-23. PubMed ID: 16242776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-trans retinoic acid inhibits KIT activity and induces apoptosis in gastrointestinal stromal tumor GIST-T1 cell line by affecting on the expression of survivin and Bax protein.
    Hoang TC; Bui TK; Taguchi T; Watanabe T; Sato Y
    J Exp Clin Cancer Res; 2010 Dec; 29(1):165. PubMed ID: 21159206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of cell killing by ABT-737 synergized with docetaxel in human prostate cancer PC-3 cells].
    Hao JW; Mao XP; Ding DG; Du GH; Liu ZH
    Zhonghua Wai Ke Za Zhi; 2012 Feb; 50(2):161-5. PubMed ID: 22490358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.